Autosomal Dominant Polycystic Kidney Disease: 2026 Clinical Updates
Autosomal Dominant Polycystic Kidney Disease: 2026 Clinical Updates
October 21, 2026 | 07:00 AM - 06:00 PM
Location: Mile High Ballroom 4D, Convention Center
Session Description
ADPKD, the most common hereditary kidney disorder, is the fourth leading cause of ESKD and can cause life-threatening extrarenal manifestations. This program provides a comprehensive, case-based update on key aspects of ADPKD care, including the context of the 2025 KDIGO ADPKD guideline.
ASN designates this live activity for a maximum of 7.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Session Objectives
Upon completion of this program, the participant will be able to: 1) describe the approach to ADPKD diagnosis, classification, and prognosis prediction; 2) discuss renal and extrarenal manifestations of ADPKD and their management; 3) explain current pharmacologic approaches and supportive care for ADPKD; and 4) identify strategies for holistic ADPKD patient-centered care.
ASN thanks the PKD Foundation for assistance with this program.
Moderators
Presentations
-
Check-In and Continental Breakfast
-
Welcome and Introduction
-
ADPKD Diagnostic Criteria, Risk Stratification, and Prognosis Prediction
-
Management of Non-CKD Renal Complications in ADPKD
-
Break
-
Management of CKD Complications in ADPKD, Including ESKD Care
-
ADPKD-Focused Drug Therapies
-
Lunch (on your own)
-
Management of Liver Complications in ADPKD
-
Screening and Management of ADPKD-Related Intracranial Aneurysms
-
Psychosocial Complications and Care in ADPKD
-
Break
-
Pregnancy, Maternal, and Fetal Outcomes and Care in ADPKD
-
Care of Children with ADPKD
-
Panel Discussion: Holistic ADPKD Patient-Centered Care
-
Closing Remarks